Advertisement
Screener

MUSTANG BIO, INC. (MBIO) Increase (Decrease) in Notes Payable, Related Parties

2.8 / 5 stars · 68/120 Roast Me

MUSTANG BIO, INC. Increase (Decrease) in Notes Payable, Related Parties

MUSTANG BIO, INC. (MBIO) reported Increase (Decrease) in Notes Payable, Related Parties of $0 for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-13.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInNotesPayableRelatedParties · last filed 2018-08-13

  • MUSTANG BIO, INC. increase (decrease) in notes payable, related parties for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
  • MUSTANG BIO, INC. increase (decrease) in notes payable, related parties for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
  • MUSTANG BIO, INC. increase (decrease) in notes payable, related parties for the quarter ending 2017-06-30 was $118.00K.
  • MUSTANG BIO, INC. increase (decrease) in notes payable, related parties for the quarter ending 2017-03-31 was $28.00K.
Period endIncrease (Decrease) in Notes Payable, Related Parties 3 monthIncrease (Decrease) in Notes Payable, Related Parties 6 month
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13
$0.00
10-Q · filed 2018-08-13
2018-03-31$0.00
10-Q · filed 2018-05-14
2017-06-30$118.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13
$146.00K
10-Q · filed 2018-08-13
2017-03-31$28.00K
10-Q · filed 2018-05-14
2016-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$0.00
10-Q · filed 2017-08-14
2016-03-31$0.00
10-Q · filed 2017-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B